Status:
COMPLETED
Assessment of the Clinical Efficacy and Acceptability of Think Positive (T+) in Diabetes Management
Lead Sponsor:
University College London Hospitals
Collaborating Sponsors:
University College, London
Department of Health, United Kingdom
Conditions:
Diabetes (Insulin-requiring, Type 1 or Type 2)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
New telemedicine systems have been designed to assist people suffering from diabetes in the management of their chronic disease. More recently the focus has been moving to portable systems equipped wi...
Eligibility Criteria
Inclusion
- Type 1 and type 2 diabetes patients
- Insulin requiring patients
- Sufficiently fluent in english
- HbA1c \> 7.5
- Last visit with Diabetes Specialist Nurse (DSN) \< 12 months
Exclusion
- Psychiatric disorders
- Poor vision or/and lack of manual dexterity
- Prior use of T+
- Participation in another ongoing trial
- Patients with antenatal/gestational
- Patients who are in transition between the children services and adult services Insulin pump users
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00922376
Start Date
June 1 2010
End Date
November 1 2011
Last Update
April 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London (UCL)
London, United Kingdom, W1W 7EJ